Literature DB >> 23989931

Loss of a negative feedback loop involving pea3 and cyclin d2 is required for pea3-induced migration in transformed mammary epithelial cells.

Franck Ladam1, Isabelle Damour, Patrick Dumont, Zoulika Kherrouche, Yvan de Launoit, David Tulasne, Anne Chotteau-Lelievre.   

Abstract

UNLABELLED: The Ets family transcription factor Pea3 (ETV4) is involved in tumorigenesis especially during the metastatic process. Pea3 is known to induce migration and invasion in mammary epithelial cell model systems. However, the molecular pathways regulated by Pea3 are still misunderstood. In the current study, using in vivo and in vitro assays, Pea3 increased the morphogenetic and tumorigenic capacity of mammary epithelial cells by modulating their cell morphology, proliferation, and migration potential. In addition, Pea3 overexpression favored an epithelial-mesenchymal transition (EMT) triggered by TGF-β1. During investigation for molecular events downstream of Pea3, Cyclin D2 (CCND2) was identified as a new Pea3 target gene involved in the control of cellular proliferation and migration, a finding that highlights a new negative regulatory loop between Pea3 and Cyclin D2. Furthermore, Cyclin D2 expression was lost during TGF-β1-induced EMT and Pea3-induced tumorigenesis. Finally, restored Cyclin D2 expression in Pea3-dependent mammary tumorigenic cells decreased cell migration in an opposite manner to Pea3. As such, these data demonstrate that loss of the negative feedback loop between Cyclin D2 and Pea3 contributes to Pea3-induced tumorigenesis. IMPLICATIONS: This study reveals molecular insight into how the Ets family transcription factor Pea3 favors EMT and contributes to tumorigenesis via a negative regulatory loop with Cyclin D2, a new Pea3 target gene. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23989931     DOI: 10.1158/1541-7786.MCR-13-0229

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  8 in total

1.  CIC-DUX4 Induces Small Round Cell Sarcomas Distinct from Ewing Sarcoma.

Authors:  Toyoki Yoshimoto; Miwa Tanaka; Mizuki Homme; Yukari Yamazaki; Yutaka Takazawa; Cristina R Antonescu; Takuro Nakamura
Journal:  Cancer Res       Date:  2017-04-12       Impact factor: 12.701

2.  PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.

Authors:  Zoulika Kherrouche; Didier Monte; Elisabeth Werkmeister; Luc Stoven; Yvan De Launoit; Alexis B Cortot; David Tulasne; Anne Chotteau-Lelievre
Journal:  Mol Oncol       Date:  2015-07-15       Impact factor: 6.603

3.  ETV transcriptional upregulation is more reliable than RNA sequencing algorithms and FISH in diagnosing round cell sarcomas with CIC gene rearrangements.

Authors:  Yu-Chien Kao; Yun-Shao Sung; Chun-Liang Chen; Lei Zhang; Brendan C Dickson; David Swanson; Sumathi Vaiyapuri; Farida Latif; Abdullah Alholle; Shih-Chiang Huang; Jason L Hornick; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2017-03-31       Impact factor: 4.263

4.  NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression.

Authors:  Junyi Ju; Aiping Chen; Yexuan Deng; Ming Liu; Ying Wang; Yadong Wang; Min Nie; Chao Wang; Hong Ding; Bing Yao; Tao Gui; Xinyu Li; Zhen Xu; Chi Ma; Yong Song; Marc Kvansakul; Ke Zen; Chen-Yu Zhang; Cheng Luo; Ming Fang; David C S Huang; C David Allis; Renxiang Tan; Changjiang Kathy Zeng; Jiwu Wei; Quan Zhao
Journal:  Nat Commun       Date:  2017-10-13       Impact factor: 14.919

5.  The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells.

Authors:  Oorvashi Roy Puli; Brian P Danysh; Elena McBeath; Deepankar K Sinha; Nguyet M Hoang; Reid T Powell; Heather E Danysh; Maria E Cabanillas; Gilbert J Cote; Marie-Claude Hofmann
Journal:  Neoplasia       Date:  2018-09-25       Impact factor: 5.715

6.  Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.

Authors:  Lu Zhang; Ruiting Fu; Ping Liu; Lijun Wang; Weihua Liang; Hong Zou; Wei Jia; Lin Tao
Journal:  J Ovarian Res       Date:  2021-11-04       Impact factor: 4.234

7.  Upregulated CDK16 Expression in Serous Epithelial Ovarian Cancer Cells.

Authors:  Qi Zhou; Yanni Yu
Journal:  Med Sci Monit       Date:  2015-11-07

8.  ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis.

Authors:  Mandy Dumortier; Franck Ladam; Isabelle Damour; Sophie Vacher; Ivan Bièche; Nathalie Marchand; Yvan de Launoit; David Tulasne; Anne Chotteau-Lelièvre
Journal:  Breast Cancer Res       Date:  2018-07-11       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.